| Hans-Günter Meyer-Thompson | Buprenorphin
'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study.
'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study.
Parkin S, Neale J, Strang J.
Int J Drug Policy. 2024 Jun 5;129:104470. doi: 10.1016/j.drugpo.2024.104470. Epub ahead of print. PMID: 38843737.
Abstract